APA (7th ed.) Citation

AA, S., M, A., S, Y., KW, B., MG, S., SE, C., . . . CS, C. (2017). Letter: Lipid-lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B-more evidence is needed. Authors' reply. Alimentary pharmacology & therapeutics, 46(8), 770. https://doi.org/10.1111/apt.14282

Chicago Style (17th ed.) Citation

AA, Shaheen, et al. "Letter: Lipid-lowering Effect of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B-more Evidence Is Needed. Authors' Reply." Alimentary Pharmacology & Therapeutics 46, no. 8 (2017): 770. https://doi.org/10.1111/apt.14282.

MLA (9th ed.) Citation

AA, Shaheen, et al. "Letter: Lipid-lowering Effect of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B-more Evidence Is Needed. Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 46, no. 8, 2017, p. 770, https://doi.org/10.1111/apt.14282.